These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26703691)

  • 1. Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico.
    Maldonado-Martínez G; Hunter-Mellado RF; Fernández-Santos D; Ríos-Olivares E
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010050. PubMed ID: 26703691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of and predicting factors for virologic failure in HIV-infected patients with persistent low-level viremia under antiretroviral therapy.
    Charuratananon S; Sungkanuparph S
    J Int Assoc Provid AIDS Care; 2015; 14(1):12-6. PubMed ID: 24651510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
    Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
    Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship.
    Penot P; Héma A; Bado G; Sombié D; Kaboré FN; Poda A; Michon C; Terzolo O; Traoré A; Slama L; Sawadogo A; Laurent C
    AIDS Care; 2018 Dec; 30(12):1502-1506. PubMed ID: 29991274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
    HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
    AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MONITORING THE VIRAL LOAD IN HIV PATIENTS UNDER ANTI-RETROVIRAL THERAPY (ART).
    Housny AEDMS; Azab MM; El Bahnasawy MMM; Hassan A; Mohamed AR
    J Egypt Soc Parasitol; 2016 Aug; 46(2):347-352. PubMed ID: 30152943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
    Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
    HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.
    Kukoyi O; Renner L; Powell J; Barry O; Prin M; Kusah J; Cong X; Paintsil E
    BMC Infect Dis; 2016 Feb; 16():58. PubMed ID: 26843068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
    Quiros-Roldan E; Raffetti E; Castelli F; Focà E; Castelnuovo F; Di Pietro M; Gagliardini R; Gori A; Saracino A; Fornabaio C; Sighinolfi L; Di Filippo E; Maggiolo F; Donato F
    J Antimicrob Chemother; 2016 Dec; 71(12):3519-3527. PubMed ID: 27543658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.
    Osborne BJ; Sheth PM; Yi TJ; Kovacs C; Benko E; Porte Cl; Huibner S; Le AQ; Danroth R; Baraki B; Mazzulli T; Brumme ZL; Kaul R
    J Infect Dis; 2013 Apr; 207(8):1226-34. PubMed ID: 23329849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
    Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
    BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
    Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
    JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.
    Wright ST; Hoy J; Mulhall B; Oʼconnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA
    J Acquir Immune Defic Syndr; 2014 May; 66(1):55-64. PubMed ID: 24463783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.